MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Transseptal Puncture: A Step-by-Step Procedural Guide
Knowledge of interatrial septum anatomy, appropriate equipment, and proper technique are key to successful transseptal puncture.
By Giulio Russo, MD; Maurizio Taramasso, MD, PhD; and Francesco Maisano, MD
Transcatheter Leaflet Repair for Functional MR
What will randomized trials mean for the future of mitral intervention?
By Ted Feldman, MD, FESC, FACC, MSCAI; Paul Sorajja, MD, FACC, FSCAI; Paul Grayburn, MD, FACC, FSCAI; and Francesco Maisano, MD
State of the Art of Transcatheter Mitral Annuloplasty: Present and Future
An appraisal of current and upcoming devices for direct and indirect transcatheter annuloplasty procedures.
By Shingo Kuwata, MD, PhD, and Francesco Maisano, MD
One-Year Results Published From the ACCESS-EU European Postapproval Registry of Abbott Vascular's MitraClip
September 9, 2013—Francesco Maisano, MD, et al published early and midterm outcomes of the two-phase observational ACCESS-EU study in the Journal of the American College of Cardiology (JACC) (2013;62:1052–1061).
Considerations of Mitral and Tricuspid Transcatheter Therapies
By Ted E. Feldman, MD, MSCAI, FACC, FESC, and Azeem Latib, MD
FDA Approves Abbott's Next-Generation MitraClip Device
July 12, 2018—Abbott Vascular announced approval from the FDA for the company's third-generation MitraClip transcatheter heart valve repair device.
Six-Month Data Presented for Valtech Cardio's Cardioband Annuloplasty System
February 12, 2015—Valtech Cardio, Ltd., developer of the Cardioband annuloplasty system, today announced that updated 6-month follow-up results of 20 patients in their multicenter feasibility study will be presented at JIM 2015: the Joint Interventional Meeting, which is being held in Rome, Italy on February 12–14.
Feasibility Study Evaluates 4Tech's TriCinch Transcatheter Tricuspid Valve Repair
June 20, 2016—4Tech Inc. announced that the company’s transcatheter TriCinch device for repair of the tricuspid heart valve has been used to successfully treat patients with tricuspid regurgitation in an ongoing feasibility study that is being conducted at San Raffaele Hospital in Milan, Italy, and at other sites in Italy and Europe.
Valtech Presents Feasibility Data on Cardioband Annuloplasty System
May 21, 2015—Valtech Cardio, Ltd., presented updated results of its multicenter feasibility study of the Cardioband Annuloplasty System at the EuroPCR conference, which took place May 19–22 in Paris, France.
Valtech's Cardioband Mitral Reconstruction System Receives CE Mark Approval for TMVR
September 14, 2015—Valtech Cardio, Ltd. announced that it has received European CE Mark approval for its Cardioband mitral reconstruction system, which is an implantable device with a transfemoral, transseptal delivery system for transcatheter mitral valve repair (TMVR).
Venus Medtech Acquires Cardiovalve
December 7, 2021—Venus Medtech (Hangzhou) Inc., a China-based company focused on the treatment of structural heart disease, announced its acquisition of Cardiovalve Ltd. (previously Mitraltech Ltd.), a developer of transcatheter mitral valve replacement (TMVR) and transcatheter tricuspid valve replacement (TTVR) devices that is headquartered in Israel.
Abbott's Portico TAVR System Evaluated at 30 Days in Real-World Setting
June 4, 2018—Abbott Structural Heart recently announced that data from the PORTICO I study of treatment with the company's Portico transcatheter aortic valve replacement (TAVR) therapy were presented at EuroPCR 2018 held May 22–25 in Paris, France.
FDA Approves Early Feasibility Study and Grants Breakthrough Device Designation for Cardiovalve System
February 20, 2020—Cardiovalve announced that it has received FDA approval for an early feasibility study (EFS) of its transcatheter tricuspid valve replacement system for a tricuspid regurgitation (TR) indication.
Imaging Considerations in PCI and Update on Mitral and Tricuspid Valve Interventions
By Ziad A. Ali, MD, DPhil, and Thomas Modine, MD, PhD, MBA
Transcatheter Aortic and Mitral Valve Update
The progress and promise of valvular interventions.
By Alain Cribier, MD; Vasilis Babaliaros, MD; and David Liff, MD
